Literature DB >> 16927374

Structural and biochemical advances in mammalian RNAi.

Robert E Collins1, Xiaodong Cheng.   

Abstract

RNAi is a collection of processes mediated by small RNAs that silence gene expression in a sequence-specific manner. Studies of processes as divergent as post-transcriptional gene silencing, transcriptional silencing through RNA-directed DNA methylation, or heterochromatin formation, and even RNA-guided DNA elimination have converged on a core pathway. This review will highlight recent structural and mechanistic studies illustrating siRNA and miRNA processing, RISC formation, the execution of RNAi by RISC, and the regulation of these pathways, with a specific focus on vertebrate systems. 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16927374      PMCID: PMC2688788          DOI: 10.1002/jcb.21069

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  101 in total

1.  Asymmetry in the assembly of the RNAi enzyme complex.

Authors:  Dianne S Schwarz; György Hutvágner; Tingting Du; Zuoshang Xu; Neil Aronin; Phillip D Zamore
Journal:  Cell       Date:  2003-10-17       Impact factor: 41.582

2.  Functional siRNAs and miRNAs exhibit strand bias.

Authors:  Anastasia Khvorova; Angela Reynolds; Sumedha D Jayasena
Journal:  Cell       Date:  2003-10-17       Impact factor: 41.582

3.  The crystal structure of the Argonaute2 PAZ domain reveals an RNA binding motif in RNAi effector complexes.

Authors:  Ji-Joon Song; Jidong Liu; Niraj H Tolia; Jonathan Schneiderman; Stephanie K Smith; Robert A Martienssen; Gregory J Hannon; Leemor Joshua-Tor
Journal:  Nat Struct Biol       Date:  2003-11-16

4.  Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs.

Authors:  Rui Yi; Yi Qin; Ian G Macara; Bryan R Cullen
Journal:  Genes Dev       Date:  2003-12-17       Impact factor: 11.361

5.  A micrococcal nuclease homologue in RNAi effector complexes.

Authors:  Amy A Caudy; René F Ketting; Scott M Hammond; Ahmet M Denli; Anja M P Bathoorn; Bastiaan B J Tops; Jose M Silva; Mike M Myers; Gregory J Hannon; Ronald H A Plasterk
Journal:  Nature       Date:  2003-09-25       Impact factor: 49.962

6.  R2D2, a bridge between the initiation and effector steps of the Drosophila RNAi pathway.

Authors:  Qinghua Liu; Tim A Rand; Savitha Kalidas; Fenghe Du; Hyun-Eui Kim; Dean P Smith; Xiaodong Wang
Journal:  Science       Date:  2003-09-26       Impact factor: 47.728

7.  The nuclear RNase III Drosha initiates microRNA processing.

Authors:  Yoontae Lee; Chiyoung Ahn; Jinju Han; Hyounjeong Choi; Jaekwang Kim; Jeongbin Yim; Junho Lee; Patrick Provost; Olof Rådmark; Sunyoung Kim; V Narry Kim
Journal:  Nature       Date:  2003-09-25       Impact factor: 49.962

8.  Activation of the interferon system by short-interfering RNAs.

Authors:  Carol A Sledz; Michelle Holko; Michael J de Veer; Robert H Silverman; Bryan R G Williams
Journal:  Nat Cell Biol       Date:  2003-08-24       Impact factor: 28.824

9.  Dicer is essential for mouse development.

Authors:  Emily Bernstein; Sang Yong Kim; Michelle A Carmell; Elizabeth P Murchison; Heather Alcorn; Mamie Z Li; Alea A Mills; Stephen J Elledge; Kathryn V Anderson; Gregory J Hannon
Journal:  Nat Genet       Date:  2003-10-05       Impact factor: 38.330

10.  RNAi-mediated targeting of heterochromatin by the RITS complex.

Authors:  André Verdel; Songtao Jia; Scott Gerber; Tomoyasu Sugiyama; Steven Gygi; Shiv I S Grewal; Danesh Moazed
Journal:  Science       Date:  2004-01-02       Impact factor: 47.728

View more
  11 in total

1.  Nanotechnology for energy-based cancer therapies.

Authors:  Kyle Gilstrap; Xiaoxiao Hu; Xiongbin Lu; Xiaoming He
Journal:  Am J Cancer Res       Date:  2011-03-11       Impact factor: 6.166

2.  RNAi: a novel strategy for the treatment of prion diseases.

Authors:  Qingzhong Kong
Journal:  J Clin Invest       Date:  2006-12       Impact factor: 14.808

Review 3.  Personalized cancer approach: using RNA interference technology.

Authors:  John Nemunaitis; Donald D Rao; Shi-He Liu; F Charles Brunicardi
Journal:  World J Surg       Date:  2011-08       Impact factor: 3.352

4.  Introduction--Epiphanies in epigenetics.

Authors:  Xiaodong Cheng; Robert M Blumenthal
Journal:  Prog Mol Biol Transl Sci       Date:  2011       Impact factor: 3.622

5.  High throughput genome-wide survey of small RNAs from the parasitic protists Giardia intestinalis and Trichomonas vaginalis.

Authors:  Xiaowei Sylvia Chen; Lesley J Collins; Patrick J Biggs; David Penny
Journal:  Genome Biol Evol       Date:  2009-07-06       Impact factor: 3.416

6.  Ewing's Sarcoma: Development of RNA Interference-Based Therapy for Advanced Disease.

Authors:  Olivia Simmons; Phillip B Maples; Neil Senzer; John Nemunaitis
Journal:  ISRN Oncol       Date:  2012-03-11

7.  Improving model predictions for RNA interference activities that use support vector machine regression by combining and filtering features.

Authors:  Andrew S Peek
Journal:  BMC Bioinformatics       Date:  2007-06-06       Impact factor: 3.169

8.  RNA interference in head and neck oncology.

Authors:  Agnieszka Sobecka; Wojciech Barczak; Wiktoria Maria Suchorska
Journal:  Oncol Lett       Date:  2016-09-02       Impact factor: 2.967

9.  Evidence of a tick RNAi pathway by comparative genomics and reverse genetics screen of targets with known loss-of-function phenotypes in Drosophila.

Authors:  Sebastian Kurscheid; Ala E Lew-Tabor; Manuel Rodriguez Valle; Anthea G Bruyeres; Vivienne J Doogan; Ulrike G Munderloh; Felix D Guerrero; Roberto A Barrero; Matthew I Bellgard
Journal:  BMC Mol Biol       Date:  2009-03-26       Impact factor: 2.946

Review 10.  MicroRNAs as Signaling Mediators and Biomarkers of Drug- and Chemical-Induced Liver Injury.

Authors:  Mitchell R McGill; Hartmut Jaeschke
Journal:  J Clin Med       Date:  2015-05-20       Impact factor: 4.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.